At present, the pharmaceutical equipment industry in China is still at the middle and low end of the industrial chain. The rapid growth in the past has relied more on the strong pull of domestic market demand and labor cost advantages. Industry analysts said that in the face of the new market situation, the pharmaceutical machinery industry must take the initiative to accelerate industrial restructuring.
With the advancement of science and technology, the pharmaceutical machinery industry is also evolving. Today, the traditional development model has to make "upgrade" choices in the rapidly losing base of the basic pharmaceutical machinery industry.
At present, China's pharmaceutical machinery industry has encountered more serious problems, and it is particularly manifested in the fact that the market cannot accommodate such a large production capacity. Product prices and profits have been at the lowest level in recent years. Low added value is the biggest problem in the entire pharmaceutical machinery industry.
At present, China's pharmaceutical machinery equipment industry as a whole is still in the middle and low end of the industrial chain. The past high-speed growth has relied more on the strength of domestic market demand and labor cost advantages. According to analysts in the industry, in the face of the new market situation, the pharmaceutical machinery industry must actively accelerate the adjustment of industrial structure and take the initiative to phase out low value-added backward products. Enterprises should also insist on improving the market competitiveness of medium and high-grade products as one of the core goals of transformation and upgrading. .
At the same time, these industries are also faced with the rare opportunity brought by the reverse mechanism: to adjust the unreasonable industrial structure, while controlling the excessive growth of production capacity, while increasing the elimination of backwardness and mergers and reorganization, the traditional production-oriented Change to the production and service type, improve the development level of the entire industry chain, and promote the stable development of the company.
China's pharmaceutical machinery industry is in a state of low quality, low efficiency, and low-end development. The purpose of transformation and upgrading is to become high-quality, efficient, and high-end. Relevant companies must speed up the industrialization and commercialization of technological innovations and completely solve the problem that “highly similar†does not appear in domestic high-end equipment compared with imported equipment, and promote the industry to enter a continuous, rational, and stable growth phase.
With the advancement of science and technology, the pharmaceutical machinery industry is also evolving. Today, the traditional development model has to make "upgrade" choices in the rapidly losing base of the basic pharmaceutical machinery industry.
At present, China's pharmaceutical machinery industry has encountered more serious problems, and it is particularly manifested in the fact that the market cannot accommodate such a large production capacity. Product prices and profits have been at the lowest level in recent years. Low added value is the biggest problem in the entire pharmaceutical machinery industry.
At present, China's pharmaceutical machinery equipment industry as a whole is still in the middle and low end of the industrial chain. The past high-speed growth has relied more on the strength of domestic market demand and labor cost advantages. According to analysts in the industry, in the face of the new market situation, the pharmaceutical machinery industry must actively accelerate the adjustment of industrial structure and take the initiative to phase out low value-added backward products. Enterprises should also insist on improving the market competitiveness of medium and high-grade products as one of the core goals of transformation and upgrading. .
At the same time, these industries are also faced with the rare opportunity brought by the reverse mechanism: to adjust the unreasonable industrial structure, while controlling the excessive growth of production capacity, while increasing the elimination of backwardness and mergers and reorganization, the traditional production-oriented Change to the production and service type, improve the development level of the entire industry chain, and promote the stable development of the company.
China's pharmaceutical machinery industry is in a state of low quality, low efficiency, and low-end development. The purpose of transformation and upgrading is to become high-quality, efficient, and high-end. Relevant companies must speed up the industrialization and commercialization of technological innovations and completely solve the problem that “highly similar†does not appear in domestic high-end equipment compared with imported equipment, and promote the industry to enter a continuous, rational, and stable growth phase.
Makeup Sample Box,Cardboard Gift Boxes,Corrugated Boxes,Printed Corrugated Box
Guangzhou Mingyin Packaging Trading Co.,Ltd. , https://www.mingyinpackaging.com